Rotella Capital Management’s Pfizer PFE Stock Holding History

Rotella Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$221K	Buy	+6,613	New	+$211K	15.02%	2
2016 Q1	–	Sell	-14,396	Closed	-$441K	–	185
2015 Q4	$441K	Sell	14,396 -34,849	-71%	-$1.1M	0.39%	73
2015 Q3	$1.47M	Buy	49,245 +39,267	+394%	+$1.26M	0.47%	18
2015 Q2	$317K	Sell	9,978 -3,844	-28%	-$125K	0.26%	87
2015 Q1	$457K	Buy	+13,822	New	+$439K	0.38%	47
2014 Q4	–	Sell	-11,348	Closed	-$318K	–	422
2014 Q3	$318K	Sell	11,348 -1,055	-9%	-$29.6K	0.33%	65
2014 Q2	$349K	Buy	+12,403	New	+$354K	0.3%	62
2013 Q4	–	Sell	-9,772	Closed	-$266K	–	131
2013 Q3	$266K	Buy	9,772 +1,473	+18%	+$40.1K	0.5%	56
2013 Q2	$221K	Buy	+8,299	New	+$229K	0.7%	34

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Rotella Capital Management's PFE Position: Q2 2016 in Review

Rotella Capital Management opened a new position in Pfizer (PFE) in Q2 2016: 6,613 shares worth $221K. The stake represents 15.02% of the portfolio and ranks #2 among its holdings. This is a return to the name: Rotella Capital Management previously reported a position in PFE as recently as Q4 2015.

Rotella Capital Management first reported a position in PFE in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.47M in Q3 2015. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Rotella Capital Management held 6,613 shares of Pfizer worth $221K as of Q2 2016.
Pfizer was a new Rotella Capital Management position in Q2 2016.
Pfizer made up 15.02% of Rotella Capital Management's portfolio in Q2 2016, its #2 holding.
Rotella Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 9 quarters since.
Rotella Capital Management's Pfizer position peaked at $1.47M in Q3 2015.
1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Rotella Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.